Cadrenal Therapeutics Statistics

Total Valuation

CVKD has a market cap or net worth of $31.02 million. The enterprise value is $26.65 million.

Market Cap	31.02M
Enterprise Value	26.65M

Important Dates

The next estimated earnings date is Monday, March 10, 2025, before market open.

Earnings Date	Mar 10, 2025
Ex-Dividend Date	n/a

Share Statistics

CVKD has 1.78 million shares outstanding. The number of shares has increased by 40.03% in one year.

Current Share Class	1.78M
Shares Outstanding	1.78M
Shares Change (YoY)	+40.03%
Shares Change (QoQ)	+3.45%
Owned by Insiders (%)	31.70%
Owned by Institutions (%)	4.96%
Float	1.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.30
P/TBV Ratio	9.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.00.

Current Ratio	3.69
Quick Ratio	3.44
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -125.15% and return on invested capital (ROIC) is -81.50%.

Return on Equity (ROE)	-125.15%
Return on Assets (ROA)	-70.99%
Return on Capital (ROIC)	-81.50%
Revenue Per Employee	n/a
Profits Per Employee	-$1.90M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +47.91% in the last 52 weeks. The beta is 1.30, so CVKD's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	+47.91%
50-Day Moving Average	14.96
200-Day Moving Average	10.20
Relative Strength Index (RSI)	58.52
Average Volume (20 Days)	69,594

Short Selling Information

The latest short interest is 71,999, so 4.04% of the outstanding shares have been sold short.

Short Interest	71,999
Short Previous Month	85,317
Short % of Shares Out	4.04%
Short % of Float	5.91%
Short Ratio (days to cover)	0.93

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.95M
Pretax Income	-6.24M
Net Income	-7.61M
EBITDA	-7.94M
EBIT	-7.95M
Earnings Per Share (EPS)	-$7.06

Full Income Statement

Balance Sheet

The company has $4.36 million in cash and $2,232 in debt, giving a net cash position of $4.36 million or $2.45 per share.

Cash & Cash Equivalents	4.36M
Total Debt	2,232
Net Cash	4.36M
Net Cash Per Share	$2.45
Equity (Book Value)	3.41M
Book Value Per Share	2.76
Working Capital	3.41M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-6.26M
Capital Expenditures	n/a
Free Cash Flow	-6.26M
FCF Per Share	-$3.51

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CVKD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-40.03%
Shareholder Yield	-40.03%
Earnings Yield	-24.53%
FCF Yield	-20.19%

Analyst Forecast

The average price target for CVKD is $32.00, which is 83.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$32.00
Price Target Difference	83.91%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-25.36%

Stock Forecasts

Stock Splits

The last stock split was on August 20, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Aug 20, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1